[1]
“Analysis of combination therapy with SGLT2 and DPP4 inhibitors in patients with Type 2 Diabetes Mellitus: an integrative review”, Acervo Saúde, vol. 23, no. 5, p. e12495, May 2023, doi: 10.25248/reas.e12495.2023.